Read about Prof. Idit Shachar's search for an improved treatment for chronic lymphocytic leukemia and other blood cancers. She and her team discovered a blocking antibody that showed great promise in killing cancer cells in a clinical trial. Prof. Shachar also addresses the challenges of being a woman (and mom) in science. This is WeizmannViews Issue No. 45.
February 06, 2017
October is National Breast Cancer Awareness Month, and people everywhere are running, walking, and even shopping in support – and, at the Weizmann Institute of Science, investigating, researching, and pursuing creative new ways to attack this still-insidious, too-common disease. Our devoted scientists are developing ways to detect breast cancer early, designing more effective treatments, and better preventing it in the first place. Learn what Weizmann is doing about breast cancer – and how you can help.
October 19, 2016
We're looking forward to summer and basking in the sun, so it's a good thing that May is Melanoma/Skin Cancer Detection and Prevention Month! Awareness, protection, and early diagnosis are crucial; when melanoma does develop, it is hard to fight. That's why the Weizmann Institute of Science is shedding light on skin cancer from a number of fresh angles.
May 10, 2016
Prof. Hadassa Degani has spent decades developing noninvasive methods of imaging cancer. Moving beyond her breakthrough 3TP, FDA approved for detecting breast and prostate cancer, she has patented a new technique, DTI, which identifies breast – and potentially pancreatic – cancer by tracking the movement of water in the body.
March 17, 2016
Weizmann Institute basic research is, yet again, behind the headlines: a new blood cancer therapy that uses one's own immune system to defeat the disease is stunning clinicians and giving patients hope. Trials in the U.S. have had amazing results, with critically ill leukemia patients now in remission. The breakthrough is based on decades of research by Weizmann's Prof. Zelig Eshhar, who is now working to adapt his method to other forms of cancer.
March 11, 2016
Prof. Moshe Oren has spent decades studying the p53 gene, which plays a key role in keeping healthy cells from turning cancerous. His basic research has inspired other scientists to build on his findings, potentially leading to p53-based cancer treatments. As head of the Moross Integrated Cancer Center, Prof. Oren's knowledge will be more valuable than ever.
January 05, 2016
Prof. Yair Reisner is expert at tricking the immune system into accepting trans¬plants it would normally reject. He made a lifesaving breakthrough that lets immunocompromised patients receive bone marrow from a mismatched donor, then expanded the method to leukemia patients – and as if that's not enough, he's now applying it to organ transplants.
June 19, 2015
Prostate cancer is the second leading cause of cancer-related deaths among American men. That's why Prof. Avigdor Scherz, collaborating with other leading cancer researchers, is developing a promising new treatment: vascular-targeted photodynamic therapy, or VTP. Now in clinical trials, VTP uses light and a unique drug to destroy prostate tumors.
May 28, 2015
May is Melanoma/Skin Cancer Detection and Prevention Month: the perfect opportunity to learn more about the disease – and what the Weizmann Institute of Science is doing to help.
May 12, 2015